The FDA has finally approved the first-gene therapy for Duchenne muscular dystrophy that holds as much promise as most dystrophy patients whose disease can be attributed to a particular gene. ...

Amid a notable surge in COVID-19 cases across the nation, the FDA has shifted its recommendation to prioritize the KP.2 lineage for the upcoming fall vaccines. ...